Bioleaders Corporation (142760) — Strategic Asset Allocation Index
Bioleaders Corporation (142760) has a Strategic Asset Allocation Index of 5.9% as of March 2025. Strategic assets (PP&E of ₩2.13 Billion plus long-term investments of ₩-) total ₩2.13 Billion, measured against net assets of ₩35.94 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Bioleaders Corporation (142760) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Bioleaders Corporation Strategic Asset Allocation Index (2015–2024)
This chart shows how Bioleaders Corporation's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of March 2025, the index stands at 5.9%, representing strategic assets of ₩2.13 Billion against net assets of ₩35.94 Billion KRW. See financial flexibility index of Bioleaders Corporation to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Bioleaders Corporation (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Bioleaders Corporation from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Bioleaders Corporation market cap and net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 6.5% | ₩2.41 Billion | ₩2.41 Billion | ₩- | ₩37.31 Billion | ▼ -0.8 pp |
| 2023 | 7.3% | ₩2.61 Billion | ₩2.61 Billion | ₩- | ₩35.79 Billion | ▼ -203.5 pp |
| 2022 | 210.8% | ₩45.72 Billion | ₩45.72 Billion | ₩- | ₩21.69 Billion | ▲ +108.4 pp |
| 2021 | 102.4% | ₩46.22 Billion | ₩46.22 Billion | ₩- | ₩45.11 Billion | ▼ -65.6 pp |
| 2020 | 168.0% | ₩51.42 Billion | ₩51.42 Billion | ₩- | ₩30.60 Billion | ▲ +26.4 pp |
| 2019 | 141.7% | ₩33.74 Billion | ₩33.74 Billion | ₩- | ₩23.82 Billion | ▼ -2.3 pp |
| 2018 | 144.0% | ₩33.83 Billion | ₩32.08 Billion | ₩1.75 Billion | ₩23.50 Billion | ▲ +130.7 pp |
| 2017 | 13.3% | ₩4.68 Billion | ₩3.89 Billion | ₩786.11 Million | ₩35.17 Billion | ▲ +4.7 pp |
| 2016 | 8.6% | ₩1.50 Billion | ₩1.46 Billion | ₩43.20 Million | ₩17.46 Billion | ▲ +0.2 pp |
| 2015 | 8.5% | ₩469.26 Million | ₩469.26 Million | ₩- | ₩5.55 Billion | — |